To explore the mechanism of the decreased METTL14 expression in CRC, we found that p53 and ELK1 might act as predictive transcription factors (TFs) for targeting METTL14 using PROMO, ChIPBase, and TRAP database (Fig 1A). Here, TP53 is linked to colorectal carcinoma.